Product Recalls in Wyoming

Product recalls affecting Wyoming — including food, drugs, consumer products, medical devices, and vehicles distributed to Wyoming. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,547 recalls have been distributed to Wyoming in the last 12 months.

48,219 total recalls
2,547 in last 12 months

Showing 56215640 of 13,375 recalls

DrugJune 21, 2019· Pharma-Natural Inc.

Recalled Item: TUSSLIN (Dextromethorphan HBr Recalled by Pharma-Natural Inc. Due to CGMP...

The Issue: CGMP Deviations: products were manufactured with lack of process validation,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 21, 2019· Pharma-Natural Inc.

Recalled Item: Dayma SUPER FORTE XL10 (Camphor 0.5% Recalled by Pharma-Natural Inc. Due to...

The Issue: CGMP Deviations: products were manufactured with lack of process validation,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2019· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets Recalled by Macleods Pharma Usa Inc Due to CGMP...

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2019· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium andHydrochlorothiazide Tablets 100 mg/25 mg 90 tablets...

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2019· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets Recalled by Macleods...

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2019· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets Recalled by Macleods...

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2019· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets 50 mg 1000 Tablets Recalled by Macleods Pharma...

The Issue: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: Ascorbic Acid 400 MG/ML (Non-Corn) Injection Solution Recalled by RXQ...

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL Recalled by RXQ...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: LIDOCAINE HCL 1% INJECTION SOLUTION (NPV) Recalled by RXQ Compounding LLC...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: MOXIFLOXACIN 0.5% OPHTH SOLUTION SYRINGE Recalled by RXQ Compounding LLC Due...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III) Recalled by RXQ...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: fentaNYL 0.05MG/ML INJ SOL (PF) Recalled by RXQ Compounding LLC Due to Lack...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV) Recalled by RXQ Compounding LLC...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: DEXTROSE 50% INJECTION SOLUTION (PF) VIAL Recalled by RXQ Compounding LLC...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR Recalled by RXQ Compounding...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: MITOMYCIN 0.04% (PF) OPH SOLN Recalled by RXQ Compounding LLC Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF) Recalled by RXQ Compounding...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: METHYLCOBALAMIN 1 MG/ML (MDV) INJECTABLE SOLUTION Recalled by RXQ...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2019· RXQ Compounding LLC

Recalled Item: PROCAINE HCL 20 MG/ML (MDV) INJECTABLE SOLUTION Recalled by RXQ Compounding...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund